These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11801512)

  • 1. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
    Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
    Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
    Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
    J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
    Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
    Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
    Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
    Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
    Majid MA; Smith VA; Newby AC; Dick AD
    Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy.
    Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ
    J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells.
    Grenell A; Singh C; Raju M; Wolk A; Dalvi S; Jang GF; Crabb JS; Hershberger CE; Manian KV; Hernandez K; Crabb JW; Singh R; Du J; Anand-Apte B
    Mol Metab; 2024 Oct; 88():101995. PubMed ID: 39047907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.
    Langton KP; McKie N; Curtis A; Goodship JA; Bond PM; Barker MD; Clarke M
    J Biol Chem; 2000 Sep; 275(35):27027-31. PubMed ID: 10854443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.
    Kamei M; Hollyfield JG
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2367-75. PubMed ID: 10476804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.
    Betts JHJ; Troeberg L
    Mol Vis; 2024; 30():74-91. PubMed ID: 38601018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of FGF and Hyaluronan in Choroidal Neovascularization in Sorsby Fundus Dystrophy.
    Wolk A; Hatipoglu D; Cutler A; Ali M; Bell L; Hua Qi J; Singh R; Batoki J; Karle L; Bonilha VL; Wessely O; Stoehr H; Hascall V; Anand-Apte B
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorsby fundus dystrophy: Insights from the past and looking to the future.
    Anand-Apte B; Chao JR; Singh R; Stöhr H
    J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations.
    Klenotic PA; Munier FL; Marmorstein LY; Anand-Apte B
    J Biol Chem; 2004 Jul; 279(29):30469-73. PubMed ID: 15123717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.